You Took Your Wegovy a Day Early — Here's What Actually Matters

Wegovy is injected once weekly, but the minimum safe gap between doses is four full days (96 hours), not exactly seven, so one day early may still be within that window depending on your last injection date.
Semaglutide's long half-life (approximately one week) means a single mistimed dose is unlikely to produce a serious overdose, though gastrointestinal side effects may be temporarily more pronounced.
After an early injection, simply count seven days from the date you just injected to set your new weekly day; you do not need to skip a dose or restart your schedule.
If you feel unwell, particularly with severe or persistent stomach pain, seek medical advice promptly, and report any suspected side effect through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Taking your Wegovy injection a day ahead of your usual schedule happens to plenty of people — a long weekend, a diary mix-up, payday falling on a different date than expected. The good news is that a single day's difference is unlikely to cause harm, though your next dose timing will need a small adjustment. Wegovy (semaglutide) is a once-weekly injection, and the NHS guidance for semaglutide is clear that injections must be spaced at least four days apart to stay safe. If you have taken a dose and realise it was early, the key question is how many days have passed since your previous injection, not simply whether you are on schedule. These are prescription-only medicines, and any uncertainty about what to do next is worth raising with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the timing gap really means, and how to reset your schedule safely

It's Monday and you've just realised your last injection was only six days ago

Picture the scenario: you inject on Tuesday mornings, but a bank holiday or a shift change meant Monday felt like Tuesday. You pressed the pen, and it was only afterwards that you noticed your calendar. This is exactly the kind of accidental early dose that our prescribers are asked about regularly, and if you took Wegovy a day early by mistake, you are far from alone.

The first thing to do is check the actual gap, not the day of the week. Semaglutide guidance, including the advice published on the NHS semaglutide medicines page, specifies that doses should be at least four days apart. If your last injection was six days ago and you have just taken today's dose, you are within an acceptable window. If it was only two or three days ago, that is a shorter gap and worth a quick call to your prescriber or pharmacist.

The practical fix for your schedule is straightforward: from the date of the early injection, count seven days forward. That becomes your new injection day. If you usually inject on Tuesday but injected on Monday this week, your next dose falls the following Monday. There is no need to skip a dose, and no need to go back to a lower dose because of a timing slip. Your body does not reset; the medicine is still working.

One thing to watch over the next day or two is your gastrointestinal comfort. Taking a dose slightly earlier than planned does not change what is in the injection, but if your system is sensitive during a dose increase period, you might notice nausea or loose stools more than usual. That tends to settle. It is the same reason the titration schedule exists at all, gradual steps help your body adjust.

Why a one-day difference is unlikely to cause a serious problem

Semaglutide has a long half-life of roughly one week, which is precisely why once-weekly dosing works. The medicine accumulates and clears slowly. A dose taken six days after the previous one rather than seven means the concentration in your system rises slightly sooner than planned, but not to a level that clinical evidence identifies as dangerous from a single mistiming.

The NHS guidance for weekly weight-loss injections as a class reflects this pharmacology: the four-day minimum gap rule exists as a safety buffer, not because days five, six and seven are identical in risk. One day early sits comfortably within the buffer for most people.

Where things are different is if you are in the earlier weeks of treatment or mid-titration. Side effects tend to be more noticeable at those stages, and an extra nudge in concentration can amplify nausea. Staying well-hydrated, eating smaller meals and not injecting on an empty stomach can all help. If side effects feel significant, reaching our support team is available seven days a week.

If you are curious how this differs from taking a full extra dose on top of the correct one, our page on accidentally taking too much semaglutide covers that scenario in more detail, the considerations are meaningfully different from a timing slip.

Resetting your injection day and what to tell your prescriber

The simplest approach after an early injection is to treat the date you just injected as your new anchor point. Count seven days from that date and inject again then. Repeat from there. Your injection day has shifted by one day, and that is fine, Wegovy does not require a fixed calendar day, only a consistent weekly rhythm.

If you are managing treatment through Wegovy with nume, your prescriber reviews your notes before every repeat order. When you request your next supply, it is worth noting in the consultation that your injection day changed this week. That context helps the prescriber make sure your resupply timing aligns correctly with your new schedule.

There is a fuller discussion of planning your injections around life events, including holidays and travel, in our piece on starting Wegovy before a holiday. Similar principles apply: the schedule bends, but within limits. For the clinical detail specific to intentionally shifting your day, our guide on taking Wegovy a day early explores the question from a different angle, covering when it may be appropriate to do so deliberately, and our separate page on whether you can take Wegovy a day early walks through the considerations before you make that call.

The broader point is that one missed day in either direction is rarely the thing that determines whether treatment works. Consistency over months matters far more than precision to the hour. If you find accidental timing shifts happen often, it may be worth picking an injection day that is genuinely easy to remember, Sunday evening, first thing on a specific weekday morning, whatever anchors well in your weekly routine.

When to seek medical advice rather than just resetting

Most early-injection situations resolve without any clinical input. A short note in your diary, a new reminder set on your phone, and you carry on. But there are circumstances where you should contact a healthcare professional rather than manage this alone.

Seek prompt medical attention if you experience severe stomach pain that spreads toward your back, with or without vomiting, this can be a sign of acute pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. It is rare, but it is serious enough that it should not be waited out at home. Persistent vomiting that prevents you drinking fluids, signs of dehydration such as dark urine or dizziness, or any allergic reaction (swelling, difficulty breathing, severe rash) are also reasons to get medical help quickly rather than monitoring symptoms alone.

If you are simply unsure whether your particular gap was safe given your personal medical history, that is exactly what our clinical team is there for. Our prescribers review each consultation personally, and aftercare questions are handled seven days a week. For a broader sense of how treatment with Wegovy fits into a wider weight management plan, our weight loss overview sets out the clinical picture. If you are not yet in treatment and are considering starting, you can check your eligibility through a free consultation with no obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions